151 related articles for article (PubMed ID: 17157390)
1. Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder.
Papakostas GI; Petersen T; Sklarsky KG; Nierenberg AA; Alpert JE; Fava M
Psychiatry Res; 2007 Jan; 149(1-3):195-200. PubMed ID: 17157390
[TBL] [Abstract][Full Text] [Related]
2. Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder. A replication of findings with the use of a double-blind, placebo-controlled trial of Hypericum perforatum versus fluoxetine.
Papakostas GI; Crawford CM; Scalia MJ; Fava M
Neuropsychobiology; 2007; 56(2-3):132-7. PubMed ID: 18259086
[TBL] [Abstract][Full Text] [Related]
3. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
[TBL] [Abstract][Full Text] [Related]
4. Early improvements in anxiety, depression, and anger/hostility symptoms and response to antidepressant treatment.
Farabaugh A; Sonawalla S; Johnson DP; Witte J; Papakostas GI; Goodness T; Clain A; Baer L; Mischoulon D; Fava M; Harley R
Ann Clin Psychiatry; 2010 Aug; 22(3):166-71. PubMed ID: 20680189
[TBL] [Abstract][Full Text] [Related]
5. Somatic symptoms in outpatients with major depressive disorder treated with fluoxetine.
Denninger JW; Papakostas GI; Mahal Y; Merens W; Alpert JE; Nierenberg AA; Yeung A; Fava M
Psychosomatics; 2006; 47(4):348-52. PubMed ID: 16844895
[TBL] [Abstract][Full Text] [Related]
6. Somatic symptoms as predictors of time to onset of response to fluoxetine in major depressive disorder.
Papakostas GI; Petersen TJ; Iosifescu DV; Summergrad P; Sklarsky KG; Alpert JE; Nierenberg AA; Fava M
J Clin Psychiatry; 2004 Apr; 65(4):543-6. PubMed ID: 15119918
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue.
Ninan PT; Hassman HA; Glass SJ; McManus FC
J Clin Psychiatry; 2004 Mar; 65(3):414-20. PubMed ID: 15096082
[TBL] [Abstract][Full Text] [Related]
8. Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder.
Papakostas GI; McGrath P; Stewart J; Charles D; Chen Y; Mischoulon D; Dording C; Fava M
Psychiatry Res; 2008 Oct; 161(1):116-20. PubMed ID: 18755514
[TBL] [Abstract][Full Text] [Related]
9. The response of psychotic-like symptoms to fluoxetine monotherapy in non-psychotic major depressive disorder.
Dording CM; Sinicropi-Yao L; Papakostas G; Matthews JD; Nierenberg AA; Fava M; Mischoulon D
Nord J Psychiatry; 2009; 63(5):420-5. PubMed ID: 19521922
[TBL] [Abstract][Full Text] [Related]
10. Comparing effects of citalopram with fluoxetine on sleep quality in patients with major depressive disorder.
Shahsavand-Ananloo E; Berenji F; Sadeghniiat K; Alimadadi A; Zahiroddin AR; Tabatabaee M; Abbasi-Asl M; Ghaeli P
Eur Rev Med Pharmacol Sci; 2013 May; 17(9):1155-61. PubMed ID: 23690183
[TBL] [Abstract][Full Text] [Related]
11. Type of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine.
Yang H; Chuzi S; Sinicropi-Yao L; Johnson D; Chen Y; Clain A; Baer L; McGrath PJ; Stewart JW; Fava M; Papakostas GI
Eur Arch Psychiatry Clin Neurosci; 2010 Mar; 260(2):145-50. PubMed ID: 19572158
[TBL] [Abstract][Full Text] [Related]
12. Hopelessness as a predictor of non-response to fluoxetine in major depressive disorder.
Papakostas GI; Petersen T; Homberger CH; Green CH; Smith J; Alpert JE; Fava M
Ann Clin Psychiatry; 2007; 19(1):5-8. PubMed ID: 17453655
[TBL] [Abstract][Full Text] [Related]
13. Anxiety and somatic symptoms as predictors of treatment-related adverse events in major depressive disorder.
Papakostas GI; Petersen T; Hughes ME; Nierenberg AA; Alpert JE; Fava M
Psychiatry Res; 2004 May; 126(3):287-90. PubMed ID: 15157754
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment outcomes of depression with associated anxiety: efficacy of continuation treatment with fluoxetine.
Joliat MJ; Schmidt ME; Fava M; Zhang S; Michelson D; Trapp NJ; Miner CM
J Clin Psychiatry; 2004 Mar; 65(3):373-8. PubMed ID: 15096077
[TBL] [Abstract][Full Text] [Related]
15. Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study.
Hale A; Corral RM; Mencacci C; Ruiz JS; Severo CA; Gentil V
Int Clin Psychopharmacol; 2010 Nov; 25(6):305-14. PubMed ID: 20856123
[TBL] [Abstract][Full Text] [Related]
16. A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression.
Fava M; Schaefer K; Huang H; Wilson A; Iosifescu DV; Mischoulon D; Wessel TC
J Clin Psychiatry; 2011 Apr; 72(4):473-9. PubMed ID: 21208574
[TBL] [Abstract][Full Text] [Related]
17. Comorbid medical illness and relapse of major depressive disorder in the continuation phase of treatment.
Iosifescu DV; Nierenberg AA; Alpert JE; Papakostas GI; Perlis RH; Sonawalla S; Fava M
Psychosomatics; 2004; 45(5):419-25. PubMed ID: 15345787
[TBL] [Abstract][Full Text] [Related]
18. Short-term psychodynamic psychotherapy and fluoxetine in major depressive disorder: a randomized comparative study.
Salminen JK; Karlsson H; Hietala J; Kajander J; Aalto S; Markkula J; Rasi-Hakala H; Toikka T
Psychother Psychosom; 2008; 77(6):351-7. PubMed ID: 18701831
[TBL] [Abstract][Full Text] [Related]
19. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
20. Symptom clusters in adolescent depression and differential response to treatment: a secondary analysis of the Treatment for Adolescents with Depression Study randomised trial.
Bondar J; Caye A; Chekroud AM; Kieling C
Lancet Psychiatry; 2020 Apr; 7(4):337-343. PubMed ID: 32199509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
